CN103592434B - 检测β-兴奋剂类的一步法酶联免疫检测方法及其试剂盒 - Google Patents
检测β-兴奋剂类的一步法酶联免疫检测方法及其试剂盒 Download PDFInfo
- Publication number
- CN103592434B CN103592434B CN201310091146.7A CN201310091146A CN103592434B CN 103592434 B CN103592434 B CN 103592434B CN 201310091146 A CN201310091146 A CN 201310091146A CN 103592434 B CN103592434 B CN 103592434B
- Authority
- CN
- China
- Prior art keywords
- beta
- stimulants
- kit
- enzyme
- single stage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000021 stimulant Substances 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title claims abstract description 27
- 238000002965 ELISA Methods 0.000 title claims abstract description 14
- 102000004190 Enzymes Human genes 0.000 claims abstract description 29
- 108090000790 Enzymes Proteins 0.000 claims abstract description 29
- 239000012530 fluid Substances 0.000 claims abstract description 15
- 239000012895 dilution Substances 0.000 claims abstract description 13
- 238000010790 dilution Methods 0.000 claims abstract description 13
- 239000000872 buffer Substances 0.000 claims abstract description 12
- 229960001117 clenbuterol Drugs 0.000 claims abstract description 11
- STJMRWALKKWQGH-UHFFFAOYSA-N clenbuterol Chemical compound CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 STJMRWALKKWQGH-UHFFFAOYSA-N 0.000 claims abstract description 11
- 241001465754 Metazoa Species 0.000 claims abstract description 9
- 238000004140 cleaning Methods 0.000 claims abstract description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 8
- 239000012898 sample dilution Substances 0.000 claims abstract description 7
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims abstract description 4
- 239000003550 marker Substances 0.000 claims abstract description 3
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 claims description 10
- 230000001900 immune effect Effects 0.000 claims description 10
- 229960002052 salbutamol Drugs 0.000 claims description 10
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 claims description 8
- YREYLAVBNPACJM-UHFFFAOYSA-N 2-(tert-butylamino)-1-(2-chlorophenyl)ethanol Chemical compound CC(C)(C)NCC(O)C1=CC=CC=C1Cl YREYLAVBNPACJM-UHFFFAOYSA-N 0.000 claims description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical group OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 8
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 8
- 229910052794 bromium Inorganic materials 0.000 claims description 8
- JSJCTEKTBOKRST-UHFFFAOYSA-N mabuterol Chemical compound CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(C(F)(F)F)=C1 JSJCTEKTBOKRST-UHFFFAOYSA-N 0.000 claims description 8
- 229950004407 mabuterol Drugs 0.000 claims description 8
- 239000003381 stabilizer Substances 0.000 claims description 8
- 229960000195 terbutaline Drugs 0.000 claims description 8
- 229960000859 tulobuterol Drugs 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 229940074995 bromine Drugs 0.000 claims description 6
- 239000008363 phosphate buffer Substances 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 102000014914 Carrier Proteins Human genes 0.000 claims description 5
- 108010078791 Carrier Proteins Proteins 0.000 claims description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 4
- 108010058846 Ovalbumin Proteins 0.000 claims description 4
- 230000002255 enzymatic effect Effects 0.000 claims description 4
- 229940092253 ovalbumin Drugs 0.000 claims description 4
- 230000001681 protective effect Effects 0.000 claims description 4
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 3
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 claims description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 claims description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 3
- 229940098773 bovine serum albumin Drugs 0.000 claims description 3
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims description 3
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 2
- 241001494479 Pecora Species 0.000 claims description 2
- 108010074605 gamma-Globulins Proteins 0.000 claims description 2
- 150000003016 phosphoric acids Chemical class 0.000 claims description 2
- 238000001514 detection method Methods 0.000 abstract description 12
- 238000011109 contamination Methods 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 238000003018 immunoassay Methods 0.000 abstract description 2
- 230000000155 isotopic effect Effects 0.000 abstract description 2
- 229940125388 beta agonist Drugs 0.000 description 20
- 239000007788 liquid Substances 0.000 description 13
- 238000002156 mixing Methods 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000012086 standard solution Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000011435 rock Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- -1 western Boot sieve Chemical compound 0.000 description 4
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 238000013016 damping Methods 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000003115 checkerboard titration Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000009920 food preservation Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 238000011587 new zealand white rabbit Methods 0.000 description 2
- 229940005654 nitrite ion Drugs 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 235000015277 pork Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- SSMSBSWKLKKXGG-UHFFFAOYSA-N 1-(2-chlorophenyl)-2-isopropylaminoethanol Chemical compound CC(C)NCC(O)C1=CC=CC=C1Cl SSMSBSWKLKKXGG-UHFFFAOYSA-N 0.000 description 1
- LSLYOANBFKQKPT-DIFFPNOSSA-N 5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol Chemical compound C([C@@H](C)NC[C@H](O)C=1C=C(O)C=C(O)C=1)C1=CC=C(O)C=C1 LSLYOANBFKQKPT-DIFFPNOSSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 108010008038 Synthetic Vaccines Proteins 0.000 description 1
- ZSTCZWJCLIRCOJ-DGCLKSJQSA-N Zilpaterol Chemical compound O[C@H]1[C@H](NC(C)C)CCN2C(=O)NC3=CC=CC1=C32 ZSTCZWJCLIRCOJ-DGCLKSJQSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229960003060 bambuterol Drugs 0.000 description 1
- ANZXOIAKUNOVQU-UHFFFAOYSA-N bambuterol Chemical compound CN(C)C(=O)OC1=CC(OC(=O)N(C)C)=CC(C(O)CNC(C)(C)C)=C1 ANZXOIAKUNOVQU-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229950011462 clorprenaline Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229960001022 fenoterol Drugs 0.000 description 1
- 229960002848 formoterol Drugs 0.000 description 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229960000960 zilpaterol Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310091146.7A CN103592434B (zh) | 2013-03-21 | 2013-03-21 | 检测β-兴奋剂类的一步法酶联免疫检测方法及其试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310091146.7A CN103592434B (zh) | 2013-03-21 | 2013-03-21 | 检测β-兴奋剂类的一步法酶联免疫检测方法及其试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103592434A CN103592434A (zh) | 2014-02-19 |
CN103592434B true CN103592434B (zh) | 2015-11-25 |
Family
ID=50082656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310091146.7A Active CN103592434B (zh) | 2013-03-21 | 2013-03-21 | 检测β-兴奋剂类的一步法酶联免疫检测方法及其试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103592434B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106770214A (zh) * | 2016-12-07 | 2017-05-31 | 无锡艾科瑞思产品设计与研究有限公司 | 一种禽肉中特布他林检测方法及检测盒 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1389730A (zh) * | 2002-07-12 | 2003-01-08 | 江南大学 | 一种盐酸克伦特罗酶免疫检测试剂盒及其检测方法 |
CN1766617A (zh) * | 2005-11-03 | 2006-05-03 | 北京望尔生物技术有限公司 | 检测β-兴奋剂类药物的酶联免疫试剂盒及其方法 |
CN101571542A (zh) * | 2009-06-15 | 2009-11-04 | 杭州迪恩科技有限公司 | 一种检测齐帕特罗的直接竞争法酶联免疫试剂盒 |
CN101776684A (zh) * | 2010-02-12 | 2010-07-14 | 上海优你生物科技股份有限公司 | 一种克伦特罗检测试剂盒及其使用方法 |
CN101799469A (zh) * | 2010-03-17 | 2010-08-11 | 北京阿匹斯生物技术有限公司 | 检测残留的盐酸克伦特罗的酶联免疫试剂盒及其检测方法 |
CN102435729A (zh) * | 2011-12-02 | 2012-05-02 | 杭州迪恩科技有限公司 | 一种快速检测三聚氰胺的一步法酶联免疫检测方法及其试剂盒 |
CN102608310A (zh) * | 2012-02-21 | 2012-07-25 | 天津康利缘生物工程有限公司 | 一种沙丁胺醇酶联免疫试剂盒及其使用方法 |
CN202735351U (zh) * | 2012-06-28 | 2013-02-13 | 无锡中德伯尔生物技术有限公司 | 一种盐酸克伦特罗酶联免疫检测试剂盒 |
-
2013
- 2013-03-21 CN CN201310091146.7A patent/CN103592434B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1389730A (zh) * | 2002-07-12 | 2003-01-08 | 江南大学 | 一种盐酸克伦特罗酶免疫检测试剂盒及其检测方法 |
CN1766617A (zh) * | 2005-11-03 | 2006-05-03 | 北京望尔生物技术有限公司 | 检测β-兴奋剂类药物的酶联免疫试剂盒及其方法 |
CN101571542A (zh) * | 2009-06-15 | 2009-11-04 | 杭州迪恩科技有限公司 | 一种检测齐帕特罗的直接竞争法酶联免疫试剂盒 |
CN101776684A (zh) * | 2010-02-12 | 2010-07-14 | 上海优你生物科技股份有限公司 | 一种克伦特罗检测试剂盒及其使用方法 |
CN101799469A (zh) * | 2010-03-17 | 2010-08-11 | 北京阿匹斯生物技术有限公司 | 检测残留的盐酸克伦特罗的酶联免疫试剂盒及其检测方法 |
CN102435729A (zh) * | 2011-12-02 | 2012-05-02 | 杭州迪恩科技有限公司 | 一种快速检测三聚氰胺的一步法酶联免疫检测方法及其试剂盒 |
CN102608310A (zh) * | 2012-02-21 | 2012-07-25 | 天津康利缘生物工程有限公司 | 一种沙丁胺醇酶联免疫试剂盒及其使用方法 |
CN202735351U (zh) * | 2012-06-28 | 2013-02-13 | 无锡中德伯尔生物技术有限公司 | 一种盐酸克伦特罗酶联免疫检测试剂盒 |
Non-Patent Citations (2)
Title |
---|
动物组织中盐酸克伦特罗残留ELISA检测试剂盒的研制;李平等;《免疫学杂志》;20060630;s178-181 * |
盐酸克伦特罗的酶联免疫分析试剂盒的研制—Ⅰ克伦特罗人工抗原及抗体的制备;李利东等;《中国卫生检验杂志》;20140228;124-126 * |
Also Published As
Publication number | Publication date |
---|---|
CN103592434A (zh) | 2014-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103941017B (zh) | C反应蛋白检测试剂盒 | |
CN103018450B (zh) | 一种氯霉素的化学发光酶联免疫检测试剂盒的制备方法 | |
CN100501404C (zh) | 检测β-兴奋剂类药物的酶联免疫试剂盒及其方法 | |
CN104655847A (zh) | 检测阿德呋啉的酶联免疫试剂盒及其检测方法 | |
CN106932589A (zh) | 测定人体血清视黄醇结合蛋白含量的试剂盒及其制备方法 | |
CN108445230B (zh) | 基于纳米抗体的降钙素原化学发光检测试剂及检测方法 | |
CN103630689B (zh) | 一种检测西马特罗药物残留的酶联免疫试剂盒及其制备方法与应用 | |
CN105866407A (zh) | 一种曲霉菌半乳甘露聚糖抗原免疫检测试剂盒及其制备方法与应用 | |
CN102967709A (zh) | 检测玉米赤霉烯酮药物的酶联免疫试剂盒及其应用 | |
CN102080067B (zh) | 一种检测呕吐毒素的方法及其专用试剂盒 | |
CN101561433B (zh) | 一种原料乳和乳制品中总蛋白含量的酶联免疫检测方法及试剂盒 | |
CN101299045B (zh) | 检测氟苯尼考及氟苯尼考胺的方法及其专用酶联免疫试剂盒 | |
CN103421072A (zh) | 地塞米松半抗原及其制备方法和应用 | |
CN101349693A (zh) | 一种氟苯尼考类药物快速检测试剂盒及其应用 | |
CN103048476A (zh) | 一种甲状腺素的纳米磁微粒化学发光测定试剂盒及其制备方法和检测方法 | |
CN103513035B (zh) | 一种检测黄曲霉毒素m1的试纸条及方法 | |
CN101592658A (zh) | 一种沙丁胺醇酶联免疫检测试剂盒及其应用 | |
CN101592660A (zh) | 布鲁氏菌病间接酶联免疫吸附试验奶液抗体检测试剂盒 | |
CN102749456B (zh) | 血管紧张素ⅰ化学发光免疫定量检测试剂盒及其制备方法 | |
CN107271665A (zh) | 一种检测沙丁胺醇的试纸条及其应用 | |
CN102495212A (zh) | 快速检测微囊藻毒素的方法和试纸 | |
CN103592434B (zh) | 检测β-兴奋剂类的一步法酶联免疫检测方法及其试剂盒 | |
CN103288661A (zh) | 一种孔雀石绿半抗原制备方法及其应用 | |
CN102680696A (zh) | 一种检测花生过敏成分Arah1的双抗体夹心ELISA方法 | |
CN103197077A (zh) | 一种检测微量牛免疫球蛋白g的试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 310023 A401-403 room, No. 16, No. 1, Ho Ho Road, Xihu District, Zhejiang, Hangzhou Applicant after: HANGZHOU DNA SCI-TECH CO., LTD. Address before: 310023, building 2, building B3, No. 181, Wuchang Road, Yuhang District, Zhejiang, Hangzhou, China Applicant before: DNA Sci-tech Co., Ltd. |
|
CB03 | Change of inventor or designer information |
Inventor after: Xu Huali Inventor after: Li Liang Inventor after: Zhang Mingzhou Inventor after: Wang Minzi Inventor after: Wei Jianliang Inventor after: Cheng Ye Inventor after: Xu Huali, Li Liang, Zhang Mingzhou, Wang Minzi, Wei Jianliang, Cheng ye, Ying Yongfei Inventor before: Xu Huali Inventor before: Li Liang Inventor before: Zhang Mingzhou Inventor before: Wang Minzi Inventor before: Wei Jianliang Inventor before: Cheng Ye |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: One-step method enzyme-linked immunosorbent assay method and kit for detection of beta-excitants Effective date of registration: 20170316 Granted publication date: 20151125 Pledgee: The Agricultural Bank of the West Branch of Hangzhou Chinese Limited by Share Ltd Pledgor: HANGZHOU DNA SCI-TECH CO., LTD. Registration number: 2017330000021 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200904 Granted publication date: 20151125 Pledgee: The Agricultural Bank of the West Branch of Hangzhou Chinese Limited by Share Ltd. Pledgor: Zhejiang Dean Biotechnology Co.,Ltd. Registration number: 2017330000021 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |